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Abstract
Background: The aim of this study is to validate the questionnaire ECOS-16 (Assessment of health related quality of
life in osteoporosis) for the evaluation of health related quality of life (HRQoL) in post-menopausal women with
osteoporosis.
Methods: An observational, prospective and multi-centre study was carried out among post-menopausal women with
osteoporosis in primary care centres and hospital outpatient clinics. All patients attended 2 visits: at baseline and at 6
months. In addition, the subgroup of outpatients attended another visit a month after the baseline to assess the test-
retest reliability. The psychometric properties of the questionnaire were evaluated in terms of feasibility, validity (content
validity and construct validity) and internal consistency in baseline, and in terms of test-retest reliability and
responsiveness to change in visit at month and visit at 6 months, respectively. In all visits, ECOS-16, EUROQoL-5D (EQ-
5D) and four 7-point items about health status (general health status, back pain, limitation in daily activities and emotional
status) were administered, whereas only outpatients were given MINI-OQLQ (Mini Osteoporosis Quality of Life
Questionnaire), besides all clinical variables; and sociodemographic variables at baseline.
Results: 316 women were consecutively included, 212 from primary care centres and 104 from hospital outpatient
clinics. Feasibility: 94.3% of patients answered all items of the questionnaire. The mean administration time was 12.3
minutes. Validity: factor analysis suggested that the questionnaire was unidimensional. In the multivariate analysis, patients
with vertebral fractures, co-morbidity and a lower education level showed to have worse HRQoL. Moderate to high
correlations were found between the ECOS-16 score and the other health status questionnaires (0.47–0.82). Reliability:
internal consistency (Cronbach's α) was 0.92 and test-retest reliability (ICC) was 0.80. Responsiveness to change: ECOS-
16 scores increased according to change perceived by the patient, as well as the effect size (ranges between 1.35 to 0.43),
the greater the perception of change in patients' general health status, the greater the changes in patients' scores. The
Minimal Clinically Important Difference (MCID) suggested a change of 0.5 points in the ECOS-16 score, representing the
least improvement in general health status due to their osteoporosis: "slightly better".
Conclusion: ECOS-16 has been proven preliminarily to have good psychometric properties, so that it can be potentially
a useful tool to evaluate HRQoL of post-menopausal women with osteoporosis in research and routine clinical practice.
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Background
Osteoporosis is characterised by low bone mass and a
deterioration in bone tissue micro-architecture, leading to
increasing bone weakness and consequently risk of frac-
ture. The most common clinical complications of oste-
oporosis are hip fracture, vertebral deformity and wrist
fracture. According to bone densitometry values, oste-
oporosis affects approximately 2 million women in Spain
[1,2]. The most frequent symptom of osteoporosis is low
back pain resulting from vertebral fractures. This pain can
have a considerable impact on the ability to carry out
usual activities of daily living. Patients are unable to work
normally, are limited in their social and leisure activities,
and may be severely affected emotionally [3].
To date, clinical trials on osteoporosis have been based on
outcomes measured by imaging tests. But these measure-
ments do not adequately reflect the extent to which the
patient is affected in their usual daily activities, and are
not appropriate to assess patients' disability and symp-
toms [4]. Nevertheless, recently some specific Health
Related Quality of Life (HRQoL) questionnaires such as
OPAQ (Osteoporosis Assessment Questionnaire) have
been used as the main outcome in clinical studies on oste-
oporosis [5]. Several generic HRQoL questionnaires, such
as the Sickness Impact Profile (SIP), SF-36 or the Notting-
ham Health Profile (NHP), have been used more fre-
quently to assess the impact of osteoporosis on HRQoL
[6]. These questionnaires are applicable to any population
and disease, thereby enabling comparison between sub-
jects suffering from different diseases. However, they have
serious limitations given the fact that they fail to explore
in detail the specific aspects of osteoporosis. For instance,
some studies have shown that certain aspects, such as the
fear of falling and suffering a bone fracture, the inability
to adequately carry out domestic tasks, the ability to dress
oneself adequately without help and despair about an
uncertain future are all stressful for these patients [7].
These items are not included in generic questionnaires
and their omission could lead to an incomplete or biased
evaluation of HRQoL of patients with osteoporosis.
Disease specific questionnaires for osteoporosis are avail-
able, such as the Osteoporosis Quality of Life Question-
naire (OQLQ) [8] or the Quality of Life Questionnaire of
the European Foundation for Osteoporosis (QUALEFFO)
[9]. However, their limited applicability due to their
length and time for administration have restricted their
use to clinical trials and highlighted the need for the
development of questionnaires which are easier to admin-
ister in routine clinical practice. In order to expand their
use in clinical practice, it is necessary to develop valid,
short, easy to administer and comprehensible question-
naires. For this reason, a specific short form HRQoL ques-
tionnaire for women with osteoporosis was developed
[10]. Its items were obtained from the Spanish versions of
the OQLQ and QUALEFFO questionnaires, and were then
reduced by using the Rasch analysis to obtain a total of 16
items; 12 from the QUALEFFO and 4 from the OQLQ.
These questionnaires were selected because they were the
only questionnaires already validated in Spain. More
information regarding the development process of the
ECOS-16 has been published elsewhere [11,12].
The aim of the present study is to evaluate the psychomet-
ric properties of the ECOS-16 in post-menopausal women
with osteoporosis.
Methods
316 post-menopausal women with primary osteoporosis
attended in Primary Care Centres or in outpatient clinics
were included in the study. Diagnosis was confirmed by a
Bone Mineral Density (BMD) using Dual Energy X-Ray
Absorptiometry (DEXA). Furthermore, outpatients
should have at least one prevalent vertebral fracture con-
firmed by Genant's radiological criteria due to osteoporo-
sis, a requirement which was not essential in patients
from Primary Care Centres. 212 patients from 49 Primary
Care Centres and 104 patients attended in outpatient clin-
ics from 14 hospitals were consecutively selected and eval-
uated from March 2000 to August 2001.
All patients attended two visits, a baseline and a follow-up
visit 6 months after the inclusion. In order to evaluate test-
retest reliability, outpatients were also attended in another
follow-up visit one month after the baseline. All patients
received the study information and gave their informed
consent.
Study design
An observational, prospective and multi-centre study was
carried out for the validation of the ECOS-16 in post-men-
opausal women with vertebral fractures due to osteoporo-
sis in conditions of clinical practice. At the baseline,
feasibility together with the content and construct validity
of the ECOS-16 were evaluated. At the visit after 6
months, responsiveness to change with regard to ECOS-
16 was evaluated. Outpatients also attended another visit
a month after the inclusion so that the test-retest reliabil-
ity of the ECOS-16 could be evaluated.
In the baseline, data on the patients' sociodemographic
characteristics (age, education level) and clinical variables
(weight, height, body mass index, age at onset of meno-
pause, BMD, presence and site of vertebral and non-verte-
bral fractures, concomitant chronic diseases and received
treatment) were collected as well as the ECOS-16, the
EUROQoL-5D and four 7-point items which refer to gen-
eral health status, back pain, limitation in daily activities
and emotional status. These items were used in a previousHealth and Quality of Life Outcomes 2004, 2:41 http://www.hqlo.com/content/2/1/41
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study and showed its validity [10]. Outpatients were also
administered the Spanish version of the MINI-OQLQ
questionnaire [3].
In the two follow-up visits, any modifications to the spe-
cific treatment for osteoporosis prescribed in the baseline,
the number of concomitant treatments, and patients'
withdrawals causes were registered. Moreover, the ECOS-
16, EUROQoL-5D and the four 7-point change items were
again administered. Outpatients were again administered
the MINI-OQLQ questionnaire.
In the present study, the EQ-5D and MINI-OQLQ ques-
tionnaires were used in order to assess the validity of the
ECOS-16.
Health related quality of life questionnaires
ECOS-16
The ECOS-16 (Please see additional file 1 ([appendix])
was developed with the aim of measuring HRQoL in post-
menopausal women with osteoporosis. It is based on the
combination of two disease-specific HRQoL question-
naires for women with osteoporosis: the Osteoporosis
Quality of Life Questionnaire (OQLQ) [8] and the Qual-
ity of Life Questionnaire of the European Foundation for
Osteoporosis (QUALEFFO) [9]. The development process
consisted in five phases: Phase I-Search for common struc-
tures; Phase II-Independent OQLQ and QUALEFFO item
reduction using Rasch analysis; Phase III-OQLQ and
QUALEFFO item equating; Phase IV-Quantitative reduc-
tion of equated items; Phase V-Qualitative reduction [11].
This newly questionnaire consists of 12 items from the
QUALEFFO and 4 from the OQLQ (see Annex 1). All
items have five possible response options, although the
response options differ from one item to another. The 16
items in the new questionnaire are divided qualitatively
into four dimensions. The nature of the four dimensions
also suggests that they can be further combined to pro-
duce two summary scores that would include Physical
Function and Pain in one Physical score, and another one
that would include Fear of Illness and Psychosocial Func-
tion in a Mental score. These two summary scores could,
in turn, be combined to provide an overall score for the
questionnaire. However, although the 16 items can be
classified qualitatively into four dimensions, this is an
unidimensional questionnaire, according to the quantita-
tive analysis [11]. The score of each item ranges from 1 to
5. ECOS-16 generates a single summary score obtained
from the arithmetic mean of the answered items, so the
total score ranges from 1 (best HRQoL) to 5 (worst
HRQoL).
The time frame for the questionnaire was one week. All
items have the same weight on the overall questionnaire
score and the overall score is calculated as the mean score
of all the response items.
It is a self-administered questionnaire, apart from some
special cases (eyesight difficulties or illiteracy) where it
was acceptable for the questionnaire to be administered
by health care personnel or experienced interviewers.
EUROQoL-5D
The EUROQoL-5D (EQ-5D) is a generic HRQoL question-
naire. The EQ-5D consists of two parts: a descriptive sys-
tem and a Visual Analogue Scale (VAS) [13]. The
descriptive system contains 5 health status dimensions:
Mobility, Self-Care, Usual activities, Pain/Discomfort and
Anxiety/Depression. These dimensions are always pre-
sented in the same order, each one with 3 degrees of sever-
ity: no problems, some or moderate problems, and
extreme problems, given a value of 1, 2 and 3, respec-
tively. For each dimension, the respondent should mark
the degree of severity which best describes their actual
health status.
The VAS of the EQ-5D is a vertical scale divided into mil-
limetres along a 20 centimetres long thermometer where
the two ends are labelled "worst imaginable health state"
and "best imaginable health state" with a score of 0 and
100, respectively. The respondent should mark the point
on the thermometer which, in their opinion, best
describes their actual overall health status.
MINI-OQLQ
The MINI-OQLQ is a specific HRQoL questionnaire for
women with vertebral fractures due to osteoporosis. The
MINI-OQLQ is based on a selection of the two highest
impact items from each of the five domains of the Oste-
oporosis Quality of Life Questionnaire (OQLQ). The
MINI-OQLQ is, therefore, composed of 10 items grouped
into the same five HRQoL dimensions (symptoms, phys-
ical function, activities of daily living, emotional function
and leisure) [3].
Each item has seven response options ranging from 1
(worse HRQoL) to 7 (better HRQoL). The scoring is
obtained per dimension, by calculating the mean score of
the response items for each dimension, so that the higher
the score in each dimension, the better the resulting
HRQoL.
7-point change items (general health status, back pain, 
limitation in daily activities and emotional status) due to 
osteoporosis
Changes in four health status items were assessed through
four different items regarding the change in the patient's
overall health status: the change in the patient's general
health status due to osteoporosis, the change in theHealth and Quality of Life Outcomes 2004, 2:41 http://www.hqlo.com/content/2/1/41
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patient's back pain, the change in the patient's limitation
in daily activities and the change in the patient's emo-
tional status, all of them due to osteoporosis, with refer-
ence to the baseline. The items have seven possible
response options, ranging from "Much better" to "Much
worse" and including the category "More or less the
same". These items were designed to be self-administered
and validated in previous studies [10,14].
Statistical analysis
Double data entry was carried out with a subsequent vali-
dation to guarantee the quality and consistency of the
data. A statistical significance level of p < 0.05 was used in
all statistical tests performed. The statistical program
SPSS® for Windows version 10.0 (SPSS, Inc., Chicago, Illi-
nois) was used to carry out the entire data analysis.
Previously the statistical analysis, a Kolmogorov-Smirnov
test was conducted to assess the distribution of the varia-
bles in order to use a parametric or non-parametric tests.
With the aim to describe the study sample characteristics
and to evaluate differences among patients with and with-
out vertebral fractures a descriptive and comparative anal-
ysis was done on patients' sociodemographic
characteristics (age, education level) and clinical variables
(Body Mass Index (BMI), number of years with meno-
pause, presence or absence of non-vertebral fractures, con-
comitant diseases and received treatment during the
previous year) according to vertebral fracture presence. In
order to compare the two groups, the chi-squared test was
used, given that the variables were categorical, and the
Bonferroni correction for multiple tests.
The feasibility of the ECOS-16 was analysed on the basis
of missing data, time and method of administration. In
order to evaluate the missing data, the number and per-
centage of missing response items in the whole question-
naire as well as the number and percentage of patients
who failed to respond to any of the questionnaire's items
were both calculated. The time spent administering the
questionnaire was evaluated according to the method of
administration (self-administered or administered by an
interviewer).
The floor (percentage of patients with the lowest score)
and ceiling (percentage of patients with the highest score)
effect were calculated for each one of the ECOS-16 items
and for the overall score.
An exploratory factor analysis was used to assess the con-
tent validity of the ECOS-16, using the scores obtained
during the baseline by all patients for all 16 questionnaire
items. Factors were extracted using principal-axis factoring
method and varimax rotations. The adequacy of the factor
analysis was assessed with the Kaiser-Meyer-Olkin meas-
ure and the Bartlett's test of sphericity [15].
To evaluate the construct validity, the correlations
between the ECOS-16 scores and the patients' sociodemo-
graphic and clinical characteristics (bivariate analysis)
were analysed. Pearson's correlation coefficient was used
for continuous variables and the analysis of variance
(ANOVA) for categorical variables. A multivariate analysis
was also carried out taking the ECOS-16 score as a
dependent variable and the sociodemographic and clini-
cal variables that were significant in the bivariant analysis
as independent variables, so that any possible confound-
ing factors could be controlled. Secondly, the relationship
between the ECOS-16 and the EQ-5D scores, the four 7-
point items (general health status, back pain, limitation in
daily activities and emotional status) and the MINI-
OQLQ (only outpatients) were all analysed using Spear-
man's correlation coefficient, apart from the VAS which
was analysed using Pearson's correlation coefficient.
Higher correlations were expected between dimensions
that measure the same HRQoL aspects.
Because the lowest score in ECOS-16, in EQ-5D and in 7-
point general health status item represent the best
HRQoL, the expected correlations among their dimen-
sions would be positive. The opposite applies to the
dimensions of MINI-OQLQ and the other three 7-point
items (back pain, limitation in daily activities and emo-
tional status), where the lowest score represent the worst
HRQoL and, therefore, the expected correlations between
ECOS-16 would be negative.
The reliability of the ECOS-16 was evaluated in terms of
internal consistency and test-retest reliability. Internal
consistency was calculated by Cronbach's α coefficient
using the baseline scores of all questionnaire items. Test-
retest reliability was evaluated only for outpatients who
did not perceive a change in their general health status
due to osteoporosis after a month, as shown by the
change in 7-point general health status item (response cat-
egory: 'More or less the same'). The Intraclass Correlation
Coefficient (ICC) between the scores for both visits was
used for this analysis. The hypothesis that the standard
psychometric recommendations for Cronbach's α and
ICC were greater than or equal to 0,7 was taken as a start-
ing point for both internal consistency and test-retest reli-
ability [16].
Longitudinal validity of the ECOS-16 was evaluated by
analysing the correlations among changes registered in
the ECOS-16, and changes in the EQ-5D, changes in the
MINI-OQLQ and changes in the four 7-point change
items from baseline to visit at 6 months. For this purpose
the Spearman's correlation coefficient was used. TheHealth and Quality of Life Outcomes 2004, 2:41 http://www.hqlo.com/content/2/1/41
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expected correlations are the same as in the construct
validity.
To assess responsiveness to change, first of all, attention
has been drawn to whether the questionnaire detects the
changes which are perceived by patients between the base-
line and the visit at 6 months. In order to do so, the Stu-
dent's t-test for paired data was used. To assess the
magnitude of changes, the effect size was calculated, thus
it was establish that the changes in the patients' scores
increased at the same time that the changes perceived by
patients. In order to calculate the effect size, the change in
7-point general health status item is used [17].
The Minimal Clinically Important Difference (MCID) has
been defined as the smallest difference between the scores
in a questionnaire that the patient perceives to be benefi-
cial [14]. The MCID was calculated for those patients who,
at visit at 6 months, declared changes "slightly better" in
the general health status item (difference between the
scores from baseline and the visit at 6 months).
Results
Table 1 shows the patients' sociodemographic and clinical
characteristics evaluated according to the presence of ver-
tebral fractures.
Statistically significant differences (p < 0.01) were found
for age, concomitant diseases (patient-reported), and
length of time with menopause, it being the case that
those patients with vertebral fractures were older and had
had menopause for a longer time. In addition, those
patients with vertebral fracture were those that had
received more treatments during the previous year (p <
0.01) and also had a greater BMI (p < 0.05). However,
those patients without a vertebral fracture presented con-
comitant diseases more frequently (p < 0.01). Only 14.4%
of patients showed some type of non vertebral fracture
and about 70% had completed at least primary education
level.
Table 1: Patients' sociodemographic and clinical characteristics according to the presence of vertebral fracture
With vertebral fracture Without vertebral fracture Total
Age‡
≤ 65 years 42 (32.8%) 92 (51.4%) 134 (43.6%)
> 65 years 86 (67.2%) 87 (48.6%) 173 (56.4%)
Total 128 (100.0%) 179 (100.0%) 307 (100.0%)
Education level
No formal education 35 (28.2%) 46 (25.7%) 81 (26.7%)
Primary school 78 (62.9%) 101 (56.4%) 179 (59.1%)
Secondary school 11 (8.9%) 27 (15.1%) 38 (12.5%)
University --- 5 (2.8%) 5 (1.7%)
Total 124 (100.0%) 179 (100.0%) 303 (100.0%)
BMI†
≤ 30 94 (73,4%) 153 (83,6%) 247 (79,4%)
> 30 34 (26,6%) 30 (16,4%) 64 (20,6%)
Total 128 (100,0%) 183 (100,0%) 311 (100,0%)
Years with menopause‡
≤ 20 years 59 (46.8%) 115 (65.3%) 174 (57.6%)
> 20 years 67 (53.2%) 61 (34.7%) 128 (42.4%)
Total 126 (100.0%) 176 (100.0%) 302 (100.0%)
Non-vertebral fractures
Presence 24 (18.7%) 21 (11.4%) 45 (14.4%)
Absence 104 (81.3%) 163 (88.6%) 267 (85.6%)
Total 128 (100.0%) 184 (100.0%) 312 (100.0%)
Concomitant diseases‡
Presence 81 (62.8%) 144 (79.1%) 225 (72.3%)
Absence 48 (37.2%) 38 (20.9%) 86 (27.7%)
Total 129 (100.0%) 182 (100.0%) 311 (100.0%)
Received treatment In the previous 
year‡
Yes 92 (70.2%) 71 (38.4%) 163 (51.6%)
No 39 (29.8%) 114 (61.6%) 153 (48.4%)
Total 131 (100.0%) 185 (100.0%) 316 (100.0%)
†p < 0.05 ‡ p < 0.007Health and Quality of Life Outcomes 2004, 2:41 http://www.hqlo.com/content/2/1/41
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After the Bonferroni correction, the analysis that were still
significant (p < 0,007) were age, years with menopause,
concomitant disease and previous treatment.
At baseline, all osteoporotic patients were prescribed or
changed their treatment by the physicians, some having
changed his previous treatment but others having received
no treatment before.
The mean (SD) administration time of the questionnaire
was 12.3 (7.8) minutes for all patients, with a median of
10 minutes. In 55.1% of cases, the questionnaire was self-
administered, the remainder being administered by
health care personnel (due to eyesight difficulties or illit-
eracy). No statistically significant differences were
observed in administration times according to the type of
administration.
The 99.7% of the patients answered all items of the ques-
tionnaire. Only one patient failed to respond to any item.
A third of the items had a floor effect greater than or equal
to 20%, 38.3% in item "Do you have problems with dress-
ing?". The maximum ceiling effect was observed in 55.7%
of the patients in item "How often have you had back pain
in the last week?". In the remaining items, the ceiling
effect was lower, ranging from 1.3% to 20.3%, the highest
being in item "Are you afraid of getting a fracture?". Two
patients (0.7%) recorded the highest scores for all the
items (ceiling effect of the overall score).
Table 2: ECOS-16 scores according to patients' clinical and sociodemographic characteristics
N ECOS-16 mean (SD) score
Age
≤ 65 years 134 2.79 (0.77)
> 65 years 173 2.92 (0.82)
Total 307 2.87 (0.80)
Education level‡
No formal education 81 3.15 (0.73)
Primary school 179 2.84 (0.81)
Secondary school 38 2.46 (0.63)
University 5 1.94 (0.58)
Total 303 2.86 (0.80)
BMI†
≤ 30 247 2.81 (0.79)
> 30 64 3.06 (0.81)
Total 311 2.86 (0.80)
Years with menopause
≤ 20 years 174 2.80 (0.78)
> 20 years 128 2.95 (0.83)
Total 302 2.86 (0.81)
Vertebral fractures
Presence 131 2.94 (0.83)
Absence 185 2.81 (0.78)
Total 316 2.86 (0.80)
Non-vertebral fractures
Presence 45 2.88 (0.71)
Absence 267 2.87 (0.81)
Total 312 2.87 (0.80)
Lumbar BMD* 298 0.024
Lumbar T-score *3 0 8 - 0 . 0 0 4
Neck BMD*2 5 7 - 0 . 0 4 2
Neck T-score* 264 0.090
Concomitant diseases†
Presence 225 2.91 (0.81)
Absence 86 2.71 (0.72)
Total 311 2.85 (0.79)
Received treatment in the previous year
Yes 163 2.87 (0.77)
No 153 2.86 (0.83)
Total 316 2.86 (0.80)
*Pearson's correlation coefficient † p < 0.05 ‡ p < 0.01Health and Quality of Life Outcomes 2004, 2:41 http://www.hqlo.com/content/2/1/41
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In the factor analysis, the Kaiser-Meyer-Olkin measure
was 0.916 indicating a good sampling adequacy. The Bar-
tlett's test of sphericity (p < 0.001) made it possible to
accept the identity of the matrix correlations for the
ECOS-16 items, thus indicating the suitability of the fac-
tor analysis.
Table 2 shows the relationship between the patients' soci-
odemographic and clinical characteristics and the ECOS-
16 score. In the bivariate analysis was observed a worse
HRQoL in women with greater BMI (p < 0.05), a lower
education level (p < 0.01) and concomitant chronic dis-
eases (p < 0.05).
A multivariate analysis was carried out to identify patients'
characteristics that were related to the ECOS-16 score (the
variables entered into the multivariate analysis were age,
education level, BMI, years with menopause, non-verte-
bral fractures, concomitant diseases and received treat-
ment in previous years, all were codified as in table 1). The
results showed that the variables of education level,
number of concomitant diseases and the presence of ver-
tebral fractures were related to the ECOS-16 score. Never-
theless, the percentage of variance explained by the
variables included in the multivariate model was low,
11.1%.
Table 3 shows the relationship between the ECOS-16
score and each one of the EQ-5D's dimensions, the four 7-
point items and the MINI-OQLQ. All the EQ-5D's dimen-
sions showed a statistically significant correlation with the
ECOS-16 score, the dimensions with the greatest correla-
tion being 'Mobility', 'Self-Care' and 'Pain/Discomfort'.
The VAS was also statistically significant, with a Pearson's
correlation coefficient of 0.61. The four 7-point items
showed high correlations (greater than 0.7) with the
ECOS-16 score, the item 'Limitation in daily activities'
being the highest correlated item (0.82). The MINI-OQLQ
dimensions showed moderate but statistically significant
correlations (range: 0.47–0.73) with the ECOS-16, the
'Symptoms' and 'Leisure' dimensions having the highest
correlations (0.71 and 0.74, respectively).
The observed correlations between the changes among
ECOS-16 questionnaire and the changes among the
dimensions of the HRQoL questionnaires administered:
EQ-5D, MINI-OQLQ and the four 7-point change items
were similar to those of the construct validity (range:
0.33–0.76). All these correlations were also statistically
significant.
The internal consistency of the ECOS-16 was very high,
with a Cronbach's α coefficient of 0.92. Test-retest reliabil-
ity was analysed for 44 outpatients who declared that their
general health status due to osteoporosis had not changed
after a month, with an Intraclass Correlation Coefficient
of 0.80 and a mean (SD) score change of 0.2 (0.5) points.
Figure 1 shows the ECOS-16 patient scores for baseline
and at visit at 6 months, as well as the effect size (ES)
according to the changes in 7-point general health status
item perceived by the patient after 6 months. The greater
the perception of change in patients' general health status,
the greater the changes in patients' scores. The same hap-
pened with the effect size as the patients who declared a
'much better' change in their general health status due to
their osteoporosis at visit at 6 months had an effect size of
1.35, compared to those patients who declared a 'quite
better' change having an ES of 1.23. The Minimal Clini-
cally Important Difference (MCID) represented a mean
change (SD) in the ECOS-16 score of 0.69 points, taking
the category representing the least improvement in gen-
eral health status due to their osteoporosis: 'slightly
better'.
Discussion
The measurement of HRQoL has attracted increasing
attention as a clinically relevant outcome of research and
clinical practice. HRQoL questionnaires reflect the impact
of health care interventions on health aspects such as
physical, mental and social well-being. However, either in
clinical research and in practice, a lengthy questionnaire is
problematic for both the health care personnel and the
patient. Shortish measure attempt to minimize time and
effort as well as to increase patient interest [18]. Thus,
shortish questionnaires need to be sufficiently psycho-
metrically robust, proving that they are truly measuring
what they set out to (validity), that they measure in a reli-
able way (reliability) and that they are capable of detect-
ing real changes in perceived health status among patients
with osteoporosis (responsiveness to change).
The ECOS-16 originates from the reduction of two vali-
dated and widely used HRQoL questionnaires in oste-
oporosis patients with vertebral fracture [11]. However, in
the present study, the ECOS-16 was administered to as
many patients with fracture as those without, in order to
establish its general applicability to patients with oste-
oporosis. Although the ECOS-16 requires a short time to
be administered, self-administration was not possible in a
high percentage of patients who needed help from health
care personnel under conditions of usual clinical practice.
In the future, it would be necessary to assess whether
scores obtained through the questionnaire are maintained
once the administration method changes, which would
give more consistency to the questionnaire.
Almost all the patients responded to all the questionnaire
items. The presence of a floor effect for one third of the
questionnaire items could lead to the conclusion that theHealth and Quality of Life Outcomes 2004, 2:41 http://www.hqlo.com/content/2/1/41
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questionnaire detects changes only when the severe dis-
ease status occurs. However, according to a previous qual-
itative division [12], the floor effect is concentrated both
in the items belong to physical and psychosocial dimen-
sions as for the mobility and self-care EQ-5D dimensions
-the most conceptually equivalent- leading to think that
the study sample has a certain clinical stability.
As some previous studies, this study shows that the varia-
bles usually used to evaluate patients with osteoporosis,
such as Bone Mineral Density (BMD) and the presence of
vertebral fractures, have low or no correlation with
HRQoL scores. This finding is not new [19,20] and sug-
gests that HRQoL scores could be influenced by other fac-
tors such as personal, clinical and sociodemographic
characteristics. In this study, the fact that patient's educa-
tion level is the most significantly correlated variable
draws particular attention. However, this observation has
already been made in previous studies in patients with
musculoskeletal problems [21,22]. The presence of con-
comitant diseases and/or a higher Body Mass Index (BMI)
is scarcely correlated with HRQoL. This finding is interest-
ing when taking into account studies evaluating HRQoL
in patients with osteoporosis, whether they be descriptive
or experimental in its design. The outcomes between com-
pared groups could be underestimated if potential charac-
teristic differences, particularly the education level, are not
monitored. In this respect, the ECOS-16 apparently
remains scientifically robust in its ability to discriminate
among different education levels.
In this study, the fact that the presence of vertebral frac-
tures does not have a negative effect on HRQoL (bivariate
analysis) deserves special attention. There seems to be
some discrepancy regarding this issue in literature. Several
studies have shown that HRQoL progressively deteriorates
in relation to the presence and number of vertebral frac-
tures [23,24]. However, other studies in the same area
failed to find such a relationship [25], or have only found
it when vertebral deformity is severe, while failing to find
a relationship with any other fractures [26,27].
Recently, a significant number of studies have highlighted
the importance of the site of the vertebral fracture and its
effect on HRQoL. In this regard, it seems that the site of
vertebral fracture has a much greater effect on HRQoL
than the presence and number of vertebral fractures [28-
30]. This difference could be explained by the relative
rigidity of the thorax column in relation to the lumbar col-
umn, in the sense that mobility is more restricted when a
lumbar rather than a thoracic region fracture occurs [31].
Moreover, lumbar column deformities have probably a
greater impact on postural stability than alterations to the
thoracic column. When the severity and site of the fracture
is taken into account, fractured vertebrae in the transi-
tional thoracolumbar region have a negative impact on
HRQoL, at a Genant's degree greater than 1 [32]. Never-
theless, prospective studies addressing this issue should
be conducted in the future assessing the impact of the
time of the fracture and the site.
Although in the present study, the bivariate analysis does
not discriminate between patients with and without verte-
Table 3: Correlations between the ECOS-16 scores and the EUROQoL-5D, the four 7-point items scores and the MINI-OQLQ
N Spearman's correlation
EUROQol-5D
Mobility 315 0.643
Self-care 315 0.623
Usual activities 315 0.594
Pain/Discomfort 314 0.608
Anxiety/Depression 315 0.555
VASa 312 -0.610
General health status 316 0.712
Back pain 313 -0.741
Limitation in daily activities 313 -0.822
Emotional status 313 -0.791
MINI-OQLQ b
Symptoms 104 -0.711
Physical function 104 -0.670
Activities of daily living 104 -0.455
Emotional function 104 -0.473
Leisure 104 -0.736
aPearson's Correlation Coefficient; bOutpatients only; All correlations are statistically significant at the 0.001 levelHealth and Quality of Life Outcomes 2004, 2:41 http://www.hqlo.com/content/2/1/41
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bral fracture, the multivariate model shows that the pres-
ence of fractures is indeed significant even if the
percentage of explained variation is small. This is not sur-
prising given the fact that such analysis is dealing with
prevalent fractures in a short term observational study
[28]. The inclusion of the time spent since the fracture
occurred could improve the model, since it is well known
that pain and disability due to a fracture progressively
diminish over time [33]. However, among other health
problems, a small percentage of explained variance was
also found [33]. Nevertheless, the variables were entered
into the multiple regression analysis dichotomously, as in
table 1, an this may reduce the likelihood of finding a rela-
tionship. Therefore, it is likely that administering a
HRQoL questionnaire in conjunction with the analysis of
clinical variables could provide a better overall picture of
the osteoporosis impact on patients.
The results obtained for internal consistency and test-
retest reliability showed high levels of homogeneity
among questionnaire items and good reproducibility over
time. Moreover, the outcomes, have also been shown that
the new questionnaire effectively detects changes in
patients' perceived health status due to osteoporosis.
Expressing responsiveness to change is an important char-
acteristic of the new instrument, one which will doubtless
allow its use in clinical research. The high correlation
between the ECOS-16 and generic (EQ-5D) and specific
(MINI-OQLQ) HRQoL questionnaires corroborates this
hypothesis. It also highlights the new questionnaire's
ECOS-16 scores according to perceived changes in general health status Figure 1
ECOS-16 scores according to perceived changes in general health status
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validity by demonstrating that it measures concepts which
are closely related to already validated HRQoL question-
naires [3,13].
The mean change in score per question corresponding to
the effect size in general and to the MCID in particular is
consistent, in terms that the larger the change assessed by
the ECOS-16, the larger the effect size. Moreover, MCID is
consistent with the results of other HRQoL question-
naires, and it is useful to compare the magnitude of
changes detected between them. MCID will also be useful
in the planning of new trials, as sample size depends on
the magnitude of the difference investigators consider
clinically important and are not willing to risk failing to
detect [34].
The potential limitations of this study are mainly due to it
being unable to rely on certain variables which have
shown a clear influence on HRQoL. In particular, the
"time spent since the fracture occurred" [35] was not ana-
lysed even though the objective of the study were women
with established osteoporosis. The inclusion of prevalent
fractures and exclusion of the incidence fractures means
that a smaller variability among the patients in this study
was established and, possibly, it also means that vertebral
fractures had less influence on HRQoL. A further possible
limitation is the limited sample size, which was relatively
low to obtain statistical significance for more than one
fracture site and for a certain fracture severity. This was a
prospective, observational study with a limited follow-up
time, but under conditions of usual clinical practice it
served to prove the short-term good responsiveness of the
questionnaire and test its remaining psychometric proper-
ties. Nevertheless long term follow-up studies will be nec-
essary in the future.
The low education level of the study sample must also be
taken into account. It is consistent with previous studies
[8,9], and as in other chronic diseases, education level has
an impact on the prevalence of osteoporosis [36] and on
the preferences of patients [37]. Furthermore, the impact
of osteoporosis on HRQoL, the site of the vertebral frac-
ture, coupled with the time spent since its onset, are
extremely important variables which must be taken into
account, since traditional clinical variables -i.e. bone den-
sitometry- do not have a remarkable relationship with
HRQoL [38].
Conclusions
In conclusion, the ECOS-16 is a HRQoL questionnaire
which is short, easy to administer (although some women
need aid) and with adequate preliminary psychometric
properties. This makes the ECOS-16 potentially very use-
ful during routine clinical practice or/and research for the
treatment and follow-up of post-menopausal women
with osteoporosis. Nevertheless, its actual potential must
be proven in future clinical trials in order to recommend
its use in research and clinical practice.
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